MZI™ is now available! 

New Natural ADHD Supplement Accentrate110™ Released

 Fenix Health Science has released a natural supplement for individuals with ADHD who weigh more than 110 lbs. This new product fills a gap in the market left by the   recently discontinued Vayarin product for adults.

 BY LILLY CONSTANCE

 March 9, 2019

 Fenix Health Science has launched Accentrate110™, a natural supplement that addresses the “nutritional deficiencies known to be associated with ADHD” and   “supports attention, memory, and focus,” according to the manufacturer’s web site. The product is intended for teens and adults more than 110 lbsand fills a hole in   the market left by the discontinuation of the medical food Vayarin in March.

 According to manufacturer web site, the combination of healthy lipids and vitamins in Accentrate110™ has been formulated to meet the nutritional needs of   adolescents, teenagers, and adults with ADHD. The supplement contains Tissue-Targeted™ EPA and DHA, L-Methylfolate, Vitamin B6/B12, Vitamin D3 and   magnesium.

  1 Accentrate100™. Accentrate (May 2019). https://accentrate.com/accentrate110/

 https://www.additudemag.com/natural-adhd-supplement-released/

 

Fenix Health Science, LLC. Announces Accentrate110™ a Natural Supplement Formulated to Address Nutritional Deficiencies Known to be Associated with ADHD for Teens and Adults

Media Contact:

Sylvia France, [email protected], phone: 678-301-9958

  Accentrate110™ contains Brain Ready™ Nutrition providing a healthy, unique combination of high-quality lipids and vitamins to help manage ADHD symptoms without drug-like side effects

 Ft. Worth, Texas – May 8, 2019 – Fenix Health Science, LLC. today announced Accentrate110™ a version of their flagship product Accentrate™ designed for teens and adults. Accentrate110™, is a natural supplement formulated to address nutritional deficiencies known to be associated with ADHD for individuals that are more than 110 lbs including teenagers and adults. Accentrate110™ contains a unique combination of Tissue-Targeted™ EPA and DHA, L-Methylfolate, Vitamin B6/B12, Vitamin D3 and Magnesium.

 “Accentrate™ was originally designed to help manage to my son’s ADHD,” said Brett Bartel, chief science officer of Fenix Health Science, LLC. “As a parent, concerned about the risks of stimulant medication, we wanted to address ADHD from a nutritional approach. After the launch of Accentrate™, we were surprised by how many people were asking for an adult version.” “About 30 to 60 percent of patients diagnosed with ADHD in childhood continue to be affected into adulthood. Therefore, about 3 to 5 percent, or about 2 million, American teens suffer from ADHD. Approximately 4.4 percent of the adult U.S. population has ADHD, but less than 20 percent of these individuals seek help for it.”

 Accentrate110 is available immediately at https://accentrate.com for 60 count bottles, a 1 month supply, starting at $59.99 with a subscription.  Also, available is the option to purchase in 3 month increments for a greater discount, starting at $164.99 with a subscription.  First-time customers will receive 15% off by using promo code NEW110 which will expire on May 31, 2019.

 About Fenix Health Science, LLC

Founded in 2017, Fenix Health Science, LLC. develops nutritional supplements that are specifically formulated to address nutritional concerns related to health issues. It is our goal to develop products that heal without hurting–today and in the future.

Accentrate™, is a natural supplement that is specifically formulated to address the nutritional deficiencies known to be associated with ADHD. These supplements may be used as alternatives to medications or in conjunction with medication, which may help keep the medicinal dosage low and more effective. We developed Accentrate™ to help our son with ADHD (and Dyslexia). Since our son uses Accentrate™, we are adamant about having the highest quality standards for both the ingredients and production facilities.

Our nutritional supplements contain a unique combination of high-quality lipids and premium vitamins to help support attention and focus without the stimulant or drug-like side effects.  Our manufacturing facilities are cGMP compliant and adhere to FDA drug facility requirements.

Our product roadmap includes nutritional supplements for adolescents and adults with ADHD, as well as other mental health-related issues. Fenix Health Science, LLC. is headquartered in Ft. Worth, Texas with a satellite office in Atlanta, Georgia. 

Sales of 3 ADHD Medical Foods Discontinued in the U.S.

 Corporate parent Enzymotec announced this week that Vayarin, Vayarin Plus, and Vayacog will no longer be sold in the United States.

 BY LILLY CONSTANCE

 March 20, 2019

 Three medical foods marketed for the treatment of attention deficit disorder (ADHD or ADD) symptoms including poor concentration and memory — namely Vayarin, Vayarin Plus, and Vayacog — will no longer be sold in the United States. This discontinuation follows a statement from parent company VAYA and its corporate partner, Enzymotec, released earlier this week. VAYA cited a “lack of alignment” with the Enzymotec business strategy, and said the company is shifting its primary focus to becoming an ingredient-supplier to other companies instead of engaging with consumers directly.

 Reactions to the announcement run the gamut. Some ADDitude community members say they aren’t surprised by the discontinuation, citing a lack of evidence and studies demonstrating the nutritional therapy’s effectiveness.

 “This company looks like they’ve been trying to sneak by regulation by avoiding actual clinical trials to prove it does work and instead trying to label it a supplement,” wrote one ADDitude reader on Facebook, “but the FDA recently held fast in the stance that artificially created omega-3s cannot be considered food-based nutritional supplements and they can’t claim any medical benefits without proving them scientifically.”

 Vayarin users voiced their frustration at the discontinuation and at the company’s sudden announcement, calling it “unprofessional.”

 “I was so sad to hear that they abruptly decided to stop supplying in the U.S.,” wrote another ADDitude reader on Facebook. “I use Vayarin because I can’t tolerate regular meds. I’m saddened and angered by the way they’ve gone about it — suddenly discontinuing, instead of giving some warning so we could get in an order to bridge the time until we can find something else.”

 ADDitude contacted Enzymotec for further information, however representatives have not returned our phone call.

 Meanwhile, competitor Accentrate — also a non-drug nutritional supplement that addresses lipid imbalances — is already courting Vayarin customers on its web site and YouTube channel. For additional treatment options, consult ADDitude’s Medications and Treatments page.

Three medical foods marketed for the treatment of attention deficit disorder (ADHD or ADD) symptoms including poor concentration and memory — namely Vayarin, Vayarin Plus, and Vayacog — will no longer be sold in the United States. This discontinuation follows a statement from parent company VAYA and its corporate partner, Enzymotec, released earlier this week. VAYA cited a “lack of alignment” with the Enzymotec business strategy, and said the company is shifting its primary focus to becoming an ingredient-supplier to other companies instead of engaging with consumers directly.

 Reactions to the announcement run the gamut. Some ADDitude community members say they aren’t surprised by the discontinuation, citing a lack of evidence and studies demonstrating the nutritional therapy’s effectiveness.

 “This company looks like they’ve been trying to sneak by regulation by avoiding actual clinical trials to prove it does work and instead trying to label it a supplement,” wrote one ADDitude reader on Facebook, “but the FDA recently held fast in the stance that artificially created omega-3s cannot be considered food-based nutritional supplements and they can’t claim any medical benefits without proving them scientifically.”

 Vayarin users voiced their frustration at the discontinuation and at the company’s sudden announcement, calling it “unprofessional.”

 “I was so sad to hear that they abruptly decided to stop supplying in the U.S.,” wrote another ADDitude reader on Facebook. “I use Vayarin because I can’t tolerate regular meds. I’m saddened and angered by the way they’ve gone about it — suddenly discontinuing, instead of giving some warning so we could get in an order to bridge the time until we can find something else.”

 ADDitude contacted Enzymotec for further information, however representatives have not returned our phone call.

 Meanwhile, competitor Accentrate — also a non-drug nutritional supplement that addresses lipid imbalances — is already courting Vayarin customers on its web site and YouTube channel. For additional treatment options, consult ADDitude’s Medications and Treatments page.

 https://www.additudemag.com/vayarin-discontinued-effective-immediately/

 
Close Menu
By pressing continue you acknowledge that you are signing up for an Auto Ship service. This means Fenix Health Science, LLC, the makers of Accentrate (TM) ,will automatically charge your card on the day it is scheduled to renew. All changes or cancellations must be made prior to the renewal date.
×

Cart